Hjem › Epitelcellekarcinom i eggstokkene › North Carolina
Kliniske studier for Epitelcellekarcinom i eggstokkene i North Carolina
9 studier for Epitelcellekarcinom i eggstokkene søker deltakere på steder i North Carolina.
Byer i North Carolina
Offisiell studietekst (engelsk)
A Study to Assess Anti-Tumor Activity of Intravenously (IV) Infused Carboplatin With Mirvetuximab Soravtansine in Participants With Newly Diagnosed Folate Receptor Alpha (FRα)Expressing Advanced-Stage Serous Epithelial Ovarian, Fallopian Tube or Primary Peritoneal Cancer.
- University of North Carolina Medical Center /ID# 275307, Chapel Hill
- Atrium Health Levine Cancer Institute /ID# 274557, Charlotte
- East Carolina University - Brody School of Medicine /ID# 275770, Greenville
- og 1 flere
RekruttererFase 2
Alder 18 og eldre · Kvinner · Oppdatert 29. sep. 2026 · NCT06890338ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation
- UNC- Chapel Hill, Chapel Hill
RekruttererObservasjonsstudie
Alder 18 og eldre · Alle kjønn · Oppdatert 14. sep. 2026 · NCT05059444AZD5335 vs. Mirvetuximab Soravtansine in FRα-high and AZD5335 vs. Chemotherapy in FRα-low Platinum-resistant Ovarian Cancer
- Research Site, Chapel Hill
RekruttererFase 3
Alder 18 og eldre · Kvinner · Oppdatert 21. jul. 2026 · NCT07218809Study of Trastuzumab Deruxtecan With Bevacizumab Versus Bevacizumab Monotherapy for First-line Maintenance in HER2-Expressing Ovarian Cancer (DESTINY-Ovarian01)
- UNC Hospital, Chapel Hill
RekruttererFase 3
Alder 18 og eldre · Kvinner · Oppdatert 2. jul. 2026 · NCT06819007Autologous CAR-T Cells Targeting B7H3 in Ovarian Cancer iC9-CAR.B7-H3 T Cells
- Lineberger Comprehensive Cancer Center, Chapel Hill
RekruttererFase 1
Alder 18 og eldre · Kvinner · Oppdatert 19. mai 2026 · NCT06305299A Study of Azenosertib (ZN-c3) in Patients With Ovarian Cancer
- Site 0259, Durham
RekruttererFase 1
Alder 18 og eldre · Kvinner · Oppdatert 7. apr. 2026 · NCT04516447CATALINA-2: A Clinical Study of TORL-1-23 in Platinum-resistant Ovarian Cancer.
- Duke Cancer Center, Durham
RekruttererFase 2
Alder 18 og eldre · Kvinner · Oppdatert 23. des. 2025 · NCT06690775A Study of NX-1607 in Adults With Advanced Malignancies
- University of North Carolina, Chapel Hill
RekruttererFase 1
Alder 18 og eldre · Alle kjønn · Oppdatert 9. sep. 2025 · NCT05107674Study of Safety and Tolerability of BCA101 Monotherapy and in Combination Therapy in Patients With EGFR-driven Advanced Solid Tumors
- Levine Cancer Institute, Charlotte
RekruttererFase 1
Alder 18 og eldre · Alle kjønn · Oppdatert 15. aug. 2025 · NCT04429542Fra ClinicalTrials.gov, data hentet 6. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.